GlassScriptPhysician profile
Vickas Khemsara
NPI 1477557023
$4,315.31
in general payments reported to CMS, 2019-2025
26 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $1,065 · 2021: $581 · 2022: $406 · 2023: $425 · 2024: $298 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,208.96 | 2019-2025 | Clareon, Hydrus Microstent, Unity |
| Biotissue Holdings INC. | $287.03 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $257.72 | 2021-2024 | Cequa |
| Allergan, INC. | $218.35 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $209.97 | 2020-2023 | Acthar |
| Abbvie INC. | $131.98 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $98.47 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $89.69 | 2021 | |
| Oyster Point Pharma, INC. | $86.41 | 2022-2023 | Tyrvaya |
| Dompe US, INC. | $83.34 | 2022-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $81.22 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $80.85 | 2022-2024 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $80.26 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $74.49 | 2022-2025 | Vyzulta, Miebo, Scoutpro Osmolarity System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $68.79 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $55.52 | 2019-2020 | |
| New World Medical,INC. | $33.45 | 2020-2021 | |
| Quidel Corporation | $27.26 | 2022 | |
| Amgen INC. | $23.46 | 2024 | Tepezza |
| Rayner Intraocular Lenses Limited | $21.40 | 2022 | |
| Eyevance Pharmaceuticals LLC | $20.56 | 2021 | |
| Rxsight INC | $20.13 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Eyepoint US, INC. | $16.55 | 2019 | |
| Lkc Technologies, INC. | $13.95 | 2022 | |
| Aerie Pharmaceuticals, INC. | $12.95 | 2019 | |
| Ivantis, INC | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vickas Khemsara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.